Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Albert Cha
AddedMar 31, 2024
UpdatedMay 31, 2026
Albert Cha

Albert Cha

Board Member, AirXpanders

CrunchbaseLinkedIn

Albert Cha's Career

AirXpanders
AirXpanders

Palo Alto, CA, US

Board Member· Board
KalVista Pharmaceuticals
KalVista Pharmaceuticals

Cambridge, MA, US

Board Member· Board
APT Pharmaceuticals
APT Pharmaceuticals

Burlingame, CA, US

Board Member· Board
Tria Beauty
Tria Beauty

Dublin, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Albert Cha's Career

AirXpanders
AirXpanders
Public$150M1252005Palo Alto, CA, US
Board Member· Board

Leadership at AirXpanders

Brian ClevingerBrian ClevingerBoard Member
Barry CheskinBarry CheskinBoard Member
Frank GrilloFrank GrilloCEO
Brigitte SmithBrigitte SmithBoard Member
KalVista Pharmaceuticals
KalVista Pharmaceuticals
Acquired$292.5M02004Cambridge, MA, US
Board Member· Board

Leadership at KalVista Pharmaceuticals

Brian J. G. PereiraBrian J. G. PereiraBoard Member
Edward P FeenerEdward P FeenerCo-Founder
Martin EdwardsMartin EdwardsBoard Member
Robert HaighRobert HaighCo-Founder
T Andrew CrockettT Andrew CrockettCo-Founder
Lloyd P. AielloLloyd P. AielloCo-Founder

Similar to KalVista Pharmaceuticals

Rigel PharmaceuticalsRigel PharmaceuticalsSouth San Francisco, CA, USPharmaceuticalsest. 1996Rigel PharmaceuticalsSouth San Francisco, CA, US · est. 1996

Rigel Pharmaceuticals: A US-based biotech firm innovating small-molecule drugs for rare diseases and cancer.

Public · $192.5M155
Gilead SciencesGilead SciencesFoster City, CA, USPharmaceuticals, Therapiesest. 1987Gilead SciencesFoster City, CA, US · est. 1987

Gilead Sciences: An American biopharmaceutical firm innovating therapies for critical diseases.

Public · $2B17k
PTC TherapeuticsPTC TherapeuticsSouth Plainfield, NJ, USPharmaceuticalsest. 1998PTC TherapeuticsSouth Plainfield, NJ, US · est. 1998

PTC Therapeutics, Inc.: A US-based pharmaceutical company specializing in oral, small-molecule drugs for genetic disorders, oncology, and infectious diseases.

Public · $1.6B1.4k
AstraZenecaAstraZenecaCambridge, Cambridgeshire, GBPharmaceuticalsest. 1999AstraZenecaCambridge, Cambridgeshire, GB · est. 1999

AstraZeneca PLC: A British-Swedish firm specializing in research, manufacturing, and sales of pharmaceuticals.

Public · $3.8B83.5k
APT Pharmaceuticals
APT Pharmaceuticals
Public$54M62005Burlingame, CA, US
Board Member· Board

Leadership at APT Pharmaceuticals

Cami SamuelsCami SamuelsBoard Member
Fred M. SchwarzerFred M. SchwarzerBoard Member
David KroinDavid KroinBoard Member
Paul J SekhriPaul J SekhriBoard Member
Steve AselageSteve AselageBoard Member
Tria Beauty
Tria Beauty
Acquired$288M02003Dublin, CA, US
Board Member· Board

Leadership at Tria Beauty

Dayton MisfeldtDayton MisfeldtBoard Member
David MauneyDavid MauneyBoard Member
Peter WylesPeter WylesCEO
Tobin IslandTobin IslandFounder
Jim GlasheenJim GlasheenBoard Member
Michael ValentinoMichael ValentinoBoard Member

Similar to Tria Beauty

FutureDermFutureDermPittsburgh, PA, USProducts, Skincareest. 2012FutureDermPittsburgh, PA, US · est. 2012

FutureDerm: Your global online hub for science-backed skincare insights and products.

Angel · $682.8k5
CureSkinCureSkinBangalore, Karnataka, INSkincare, Treatment Kitsest. 2016CureSkinBangalore, Karnataka, IN · est. 2016

AI-powered skin-care solutions delivered to your doorstep. Get personalized treatment plans from CureSkin.

Series A · $5.5M30
StratiaStratiaBoston, MA, USCosmetics, Skincareest. 2016StratiaBoston, MA, US · est. 2016

Stratia: Your online destination for premium skincare products.

Seed · $2M8
Function of BeautyFunction of BeautyNew York City, NY, USHair Care, Skin Careest. 2015Function of BeautyNew York City, NY, US · est. 2015

Custom beauty brand crafting personalized hair, skin, and body care through tech and innovation.

Late Stage Private · $247.9M200

Albert Cha's Similar Executives & Operators

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoYun SeokYun SeokBoard Member · Kakao

People Similar to Albert Cha

Hiten PatelHiten PatelBoard Member · CollaberaAllen LichterAllen LichterBoard Member · CellworksJames FoghtJames FoghtBoard Member · OncolyzeAdrian AdamsAdrian AdamsBoard Member · AcelRx PharmaceuticalsDoug GivenDoug GivenBoard Member · Arrowhead PharmaceuticalsDouglas FallerDouglas FallerBoard Member · Viracta Therapeutics